# New Research Demonstrates the Advantages of an Insourced Dialysis Service Line for Acute-Care Facilities Using Outset Medical’s Tablo® Hemodialysis System
Canonical URL: https://biopharmsignal.com/news/OM/new-research-demonstrates-the-advantages-of-an-insourced-dialysis-service-line-for-acute-care-facilities-using-outset-medical-s-tablor-hemodialysis-system
Ticker: OM
Company: Outset Medical
Source: Outset Medical
Published: 2025-11-05 21:05 EST
Original Source URL: https://investors.outsetmedical.com
## Summary

Data from over 1 Million Tablo Treatments Among the Findings Presented at the American Society of Nephrology’s Kidney Week 2025 SAN JOSE, Calif. , Nov. 05, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology

## Article Body
Data from over 1 Million Tablo Treatments Among the Findings Presented at the American Society of Nephrology’s Kidney Week 2025 SAN JOSE, Calif. , Nov. 05, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology
## Recent Company News
- 2026-05-11 20:05 EST — [Outset Medical to Present at RBC Global Healthcare Conference](https://biopharmsignal.com/news/OM/outset-medical-to-present-at-rbc-global-healthcare-conference) — Source: Outset Medical
- 2026-05-07 20:02 EST — [Outset Medical Reports First-Quarter Results](https://biopharmsignal.com/news/OM/outset-medical-reports-first-quarter-results) — Source: Outset Medical
- 2026-04-27 20:05 EST — [Outset Medical to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026](https://biopharmsignal.com/news/OM/outset-medical-to-report-first-quarter-2026-financial-results-on-thursday-may-7-2026) — Source: Outset Medical
- 2026-04-08 20:05 EST — [Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/OM/outset-medical-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4) — Source: Outset Medical
- 2026-04-06 20:05 EST — [Outset Medical Names Derick Elliott as Executive Vice President of Commercial](https://biopharmsignal.com/news/OM/outset-medical-names-derick-elliott-as-executive-vice-president-of-commercial) — Source: Outset Medical
## Related News
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)
- 2026-07-29 12:25 EST — ICCM — [IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance  of ProSense®](https://biopharmsignal.com/news/ICCM/icecure-sio-petitions-nccn-to-include-cryoablation-in-breast-cancer-treatment-gu-bec46cd3)